Louisiana State Employees Retirement System Has $1.84 Million Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Louisiana State Employees Retirement System lowered its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 42.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,700 shares of the company's stock after selling 45,200 shares during the period. Louisiana State Employees Retirement System's holdings in Bath & Body Works were worth $1,840,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of BBWI. Golden State Wealth Management LLC boosted its stake in shares of Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Bath & Body Works by 109.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock valued at $63,000 after purchasing an additional 852 shares in the last quarter. Ancora Advisors LLC acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at $67,000. Finally, TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 34.9% in the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock valued at $89,000 after purchasing an additional 593 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Trading Down 1.3%

Shares of BBWI stock traded down $0.39 on Wednesday, reaching $30.80. The company had a trading volume of 4,111,062 shares, compared to its average volume of 5,247,271. The stock has a market cap of $6.52 billion, a PE ratio of 8.21, a PEG ratio of 1.07 and a beta of 1.72. The company has a 50-day moving average of $30.14 and a 200-day moving average of $32.41. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the previous year, the firm earned $0.38 EPS. Bath & Body Works's quarterly revenue was up 2.9% compared to the same quarter last year. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.60%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's dividend payout ratio (DPR) is currently 21.33%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on BBWI. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 14th. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research report on Friday, May 30th. Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. Finally, UBS Group upped their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $42.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.